Involving patients in the monitoring of radiotherapy-induced skin reactions - Document - Gale OneFile: Health and Medicine
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial - The Lancet Oncology
Oral Mucositis: Update on Prevention and Management Strategies
Evidence-Based Statistics on Complete Prevention and Rapid Sustained Elimination of Chemoradiation Mucositis by High-Potency Polymerized Cross-Linked Sucralfate - Journal of Oncology Navigation & Survivorship
JGO :: Journal of Gynecologic Oncology
Clinical response of skin and mucosa to radiation | PPT
Table 2 from Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial | Semantic Scholar
Effective management of severe radiation dermatitis after head and neck radiotherapy | MDedge Hematology and Oncology
WHO Toxicity Criteria and RTOG Acute Radiation Morbidity Scoring Criteria. | Download Table
Gastrointestinal toxicity, measured by the RTOG toxicity scale. a | Download Table
Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial | Journal of Clinical
International Braz J Urol ::
WHO Toxicity Criteria and RTOG Acute Radiation Morbidity Scoring Criteria. | Download Table
Table 1 from 8 Radiotherapy in Prostate Cancer | Semantic Scholar
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL) - ScienceDirect
Radiation Oncology Journal
Quantitative assessments of late radiation-induced skin and soft tissue toxicity and correlation with RTOG scales and biological equivalent dose in breast cancer | Clinical and Translational Oncology